Clinical Trials Logo

Non-Hodgkin Lymphoma (NHL) clinical trials

View clinical trials related to Non-Hodgkin Lymphoma (NHL).

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT02875548 Enrolling by invitation - Clinical trials for Advanced Solid Tumors

A Study to Assess the Long-term Safety of Tazemetostat

TRuST
Start date: August 30, 2016
Phase: Phase 1/Phase 2
Study type: Interventional

This study will provide continuing availability to tazemetostat for people that have previously completed participation in a tazemetostat study, either with monotherapy (single drug treatment) or combination therapy. The aim of the study will be to assess the long-term safety of tezemetostat.